Beclometason/Formoterol Cipla

Beclometasone/Formoterol Cipla is a combination inhaler used for managing asthma and chronic obstructive pulmonary disease (COPD). It combines an anti-inflammatory corticosteroid with a long-acting bronchodilator for respiratory relief.

Beclometasone/Formoterol Cipla is primarily used for the maintenance treatment of asthma and COPD. The beclometasone component helps reduce inflammation in the airways, while formoterol works as a bronchodilator to improve breathing. This combination is often prescribed for long-term management of these conditions to prevent symptoms like wheezing, shortness of breath, and coughing.

Common effects of Beclometasone/Formoterol Cipla may include throat irritation, hoarseness, and a dry mouth. Some users might experience tremors, headaches, or an increased heart rate. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Beclometasone/Formoterol Cipla should be used as directed by a healthcare professional. It is important to rinse your mouth after each use to reduce the risk of oral thrush. Patients with certain medical conditions, such as heart disease or diabetes, should use this medication with caution and under medical supervision.

Beclometasone/Formoterol Cipla may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol should be discussed with a healthcare professional.